ClearPoint Neuro, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price
ClearPoint Neuro, Inc. (CLPT) had Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price of $6.00 per share as of 2025-12-31, per its 10-K filed 2026-03-17.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue · last filed 2026-03-17
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $6.00.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $6.83.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $7.37.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $7.19.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price | Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price as first filed |
|---|---|---|
| 2025-12-31 | $6.00 10-K · filed 2026-03-17 | |
| 2024-12-31 | $6.83 10-K · filed 2026-03-17 | |
| 2023-12-31 | $7.37 10-K · filed 2025-02-26 | |
| 2022-12-31 | $7.19 10-K · filed 2024-03-12 | |
| 2021-12-31 | $5.38 10-K · filed 2023-03-01 | |
| 2020-12-31 | $2.09 10-K · filed 2022-03-09 | |
| 2019-12-31 | $1.46 10-K · filed 2021-03-22 | |
| 2018-12-31 | $1.21 10-K · filed 2021-03-22 | $0.94 10-K · filed 2019-04-01 |
| 2017-12-31 | $1.45 10-K · filed 2020-03-27 | |
| 2016-12-31 | $10.53 10-K · filed 2019-04-01 | |
| 2015-12-31 | $18.77 10-K · filed 2018-03-21 | $0.47 10-K · filed 2016-03-25 |
| 2014-12-31 | $20.80 10-K · filed 2017-03-09 | $0.52 10-K · filed 2016-03-25 |
| 2013-12-31 | $0.56 10-K · filed 2016-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |